or Try an Advanced Search...

    Technical Analysis for CLNN - Clene Inc.

    Grade Last Price % Change Price Change
    F 4.01 -1.96% -0.08
    CLNN closed down 1.96 percent on Thursday, November 21, 2024, on 1.79 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CLNN trend table...
    Date Alert Name Type % Chg
    Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Spinning Top Other 0.00%
    NR7 Range Contraction 0.00%
    180 Bearish Setup Bearish Swing Setup -1.96%
    Expansion Breakdown Bearish Swing Setup -1.96%
    Reversal New Lows Setup Bearish Swing Setup -1.96%
    Lower Bollinger Band Walk Weakness -1.96%
    Outside Day Range Expansion -1.96%
    Wide Bands Range Expansion -1.96%
    Older End-of-Day Signals for CLNN ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 5 hours ago
    Possible Inside Day about 5 hours ago
    60 Minute Opening Range Breakdown about 7 hours ago
    2x Volume Pace about 7 hours ago
    Down 3% about 7 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    CLNN Chart by TradingView
    Basic chart:

    Profile

    Clene Nanomedicine Inc., a biopharmaceutical company, develops technology solutions for drug development. The company develops Clean-Surface Nanosuspension, a technology that produces clean-surface nanocrystal medicines. Its technology also provides a platform for a pipeline of new drug candidates with application across a spectrum of diseases with unmet medical needs. The company focuses on demyelinating disorders and oncology. Clene Nanomedicine Inc. was incorporated in 2012 and is based in Salt Lake City, Utah.
    Classification
    Keywords: Biotechnology Biopharmaceutical Life Sciences Health Sciences Medication Technology Solutions Drug Development Nanomedicine

    Is CLNN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 Clene GAAP EPS of -$1.22 beats by $0.07, revenue of $0.09M misses by $0.01M
    Nov 13 Clene Reports Third Quarter 2024 Financial Results and Recent Operating Highlights
    Oct 11 IBN Coverage: Clene (NASDAQ: CLNN) Closes $7.3M Registered Direct Offering and Concurrent Private Placements
    Oct 5 Independent Chairman of the Board of Clene David Matlin Buys 26% More Shares
    Oct 3 IBN Coverage: Clene (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M
    Oct 2 IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements
    Oct 1 Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility
    Sep 26 IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership
    Sep 16 Clene Granted In-Person Meeting With FDA Senior Leadership to Discuss CNM-Au8 Biomarker and Related Clinical and Survival Data
    Sep 4 IBN Coverage: Clene (NASDAQ: CLNN) Management to Present at H.C. Wainwright Investment Conference
    See more CLNN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.0
    52 Week Low 3.8181
    Average Volume 72,560
    200-Day Moving Average 6.55
    50-Day Moving Average 5.29
    20-Day Moving Average 5.35
    10-Day Moving Average 4.76
    Average True Range 0.51
    RSI (14) 31.51
    ADX 24.15
    +DI 9.58
    -DI 23.48
    Chandelier Exit (Long, 3 ATRs) 4.97
    Chandelier Exit (Short, 3 ATRs) 5.41
    Upper Bollinger Bands 6.81
    Lower Bollinger Band 3.89
    Percent B (%b) 0.04
    BandWidth 54.66
    MACD Line -0.35
    MACD Signal Line -0.17
    MACD Histogram -0.1826
    Fundamentals Value
    Market Cap 514.95 Million
    Num Shares 128 Million
    EPS -0.41
    Price-to-Earnings (P/E) Ratio -9.78
    Price-to-Sales 73.37
    Price-to-Book 2.51
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.43
    Resistance 3 (R3) 4.44 4.31 4.36
    Resistance 2 (R2) 4.31 4.20 4.31 4.34
    Resistance 1 (R1) 4.16 4.14 4.10 4.15 4.31
    Pivot Point 4.03 4.03 4.00 4.03 4.03
    Support 1 (S1) 3.88 3.92 3.82 3.87 3.71
    Support 2 (S2) 3.75 3.86 3.75 3.68
    Support 3 (S3) 3.60 3.75 3.66
    Support 4 (S4) 3.59